Next Science Limited (ASX: NXS) is a medical technology company headquartered in Sydney, Australia, with commercial operations in Florida, USA. Next Science’s primary focus is the development and continued commercialisation of its proprietary XBIO™ technology to reduce the impact of biofilm-based infections in human health.

Shareholder meetings

2024 Annual General Meeting – 3 May 2024

Next Science will hold an Annual General Meeting on Friday, 3 May 2024 at 10.30am (Sydney time).

Notice of MeetingOpens in new window
2023 Annual ReportOpens in new window
Virtual Meeting GuideOpens in new window

Investor contacts

Investor queries

Next Science Limited
Level 14, Australia Square,
264-278 George Street, Sydney
NSW 2000
Ph: +61 412 292 977
E: [email protected]

Share Registry queries

Link Market Services Limited
Level 12, 680 George Street
Sydney NSW 2000
Ph: 1300 554 474